Nitroxoline

硝羟喹啉

Report date: 2022/11/17 20:00:51
NME

Base Information

Drug NameNitroxoline
Drug Alias NameNilox midiSanserNiniolNiloksNysin +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethionine aminopeptidase 2 inhibitorsAngiogenesis inhibitors
TargetsMethionine aminopeptidase 2
Therapy Area/IndicationsUrinary Bladder NeoplasmsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAsieris Pharmaceuticals LtdSuzhou Pharmaceutical Factory
Inactive CompaniesAsieris Pharmaceutical Technologies Co Ltd
Active IndicationsUrinary Bladder NeoplasmsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01XX07
Related LinksWikipediaDrugBankKEGG